H
Halozyme Therapeutics
San Diego, United States
Founded 1998 NASDAQ: HALO
About
ENHANZE technology enabling subcutaneous delivery of biologics
Company Details
- Type
- public
- Employees
- 500+
- Funding
- Public
Key Products
- ENHANZE
- Hylenex
ENHANZE technology enabling subcutaneous delivery of biologics